Sanofi Aventis pays Ç140,000 for 0.20% of Zentiva

Sanofi Aventis, majority shareholder of Zentiva Romania (ticker: SCD), added 825,500 shares to its majority holding in the company it owns, after drawing as little as 3.4% of the share capital in the initial public offering.
After paying 2.24 million lei (€0.51 million) on November 16 for 0.77% of Zentiva, the majority shareholder acquired another 0.20% interest.

The median price paid by the drug maker for the 825,000 shares was 0.7lei/share, similar to the IPO price, transactions totaling 596,742 lei (€139,400). Sanofi Aventis’ stake in Zentiva has thus increased to 79.28%.

French-based drug maker reported a profit of 3.21 million lei (€0.76 million) for the three quarters ending September 30, 7 times lower than the same period of last year, which indicates a 5.33 million lei loss in the third quarter 2009.

Zentiva has a share capital of 41.69 million lei, divided into 416.9 million shares at a face value of 0.1lei.

The company’s current market value is 291.87million lei (€68 million), according to Friday’s closing quote of 0.7lei/share.

Despre autor
Wall-Street.ro este un cotidian de business fondat ├«n 2005, parte a grupului InternetCorp, unul dintre cei mai mari juc─âtori din industria rom├óneasc─â de publishing online. Pe parcursul celor peste 15 ani de prezen╚Ť─â pe pia╚Ťa media, ne-am propus s─â fim o surs─â de inspira╚Ťie pentru mediul de business, dar ╚Öi un canal de educa╚Ťie pentru pentru celelalte categorii de public interesate de zona economico-financiar─â. ├Än plus, Wall-Street.ro are o experien╚Ť─â de 10 ani ├«n organizarea de evenimente B2B, timp ├«n care a sus╚Ťinut peste 100 de conferin╚Ťe pe domenii precum Ecommerce, banking, retail, pharma&s─ân─âtate sau imobiliare. Astfel, am reu╚Öit s─â avem o acoperire complet─â - online ╚Öi offline - pentru tot ce ├«nseamn─â business-ul de calitate.

Te-ar putea interesa și:


Mai multe articole din sec╚Ťiunea English »



Setari Cookie-uri